DAIC Editor Dave Fornell offers his choices of the most innovative new cardiovascular technologies discussed in sessions ...
Men undergoing testosterone therapy had a 29 percent greater risk of heart attack, stroke and death according to a study of a "real world" population of men.
Doctors have known for years that atrial fibrillation (AF) increases the risk for stroke, but now researchers at Wake Forest Baptist Medical Center have shown that it also increases the risk for heart attack.
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
Biotronik announced that the PK Papyrus covered coronary stent system has received CE mark for the treatment of acute coronary artery perforation.
SunTech Medical Advantage OEM non-invasive blood pressure (NIBP) modules provide reliable blood pressure measurement for adverse conditions during emergency medical service (EMS) transport.
Corindus Vascular Robotics presented a live percutaneous coronary intervention (PCI) during the Transcatheter Cardiovascular Therapeutics (TCT) conference on Oct. 29.
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
Researchers at Saint Luke’s Mid America Heart Institute led a study that showed marked, long-term improvement in health status in patients suffering from peripheral artery (PAD) treated with the SMART nitinol self-expandable stent.
The U.S. Food and Drug Administration (FDA) announced a Class I recall of Baylis Medical’s TorFlex Transseptal Guiding Sheath Kit device designed for catheterization specific heart chambers.
Zevacor Molecular, a healthcare firm that manufactures and distributes positron emissions tomography (PET) and single photon emission computed tomography (SPECT) radiopharmaceuticals, has purchased the first 70 MeV Cyclotron dedicated to medical use in the United States from Ion Beam Applications, S.A. (IBA).
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
A new way of using blood pressure-lowering medications could prevent more than a fourth of heart attacks and strokes — up to 180,000 per year — while using less medication overall, according to new research from the University of Michigan (U-M) Health System and the VA Ann Arbor Healthcare System.
According to Millennium Research Group (MRG), the anticipated Food and Drug Administration (FDA) approval of Boston Scientific's Watchman device will drive rapid growth in the market for global left arterial appendage (LAA) closure devices.
Scott Lim, M.D., director of the Heart Valve Center at the University of Virginia Medical Center, investigator in the ...
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
Herbert Aronow, M.D., MPH, St. Joseph Mercy Hospital, Ann Arbor, and an active member of ACC and SCAI, explains the top ...
Medtronic Inc. announced U.S. Food and Drug Administration (FDA) approval of its Lead Integrity Alert (LIA) software for use with non-Medtronic leads.
Blackford Analysis, a provider of software products that accelerate comparison of medical images, announced it will launch its complete product range at the 2013 Radiological Society of North America Scientific Assembly and Annual Meeting (RSNA 2013) in Chicago.